Plasma 5-miRNA as Biomarkers for Identifying Prostate Cancer Patients

  • Mojtaba SAFFARI 1. Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran 2. Cancer Biology Research Center, Cancer Institute of Iran, Tehran, Iran
  • Mohammad Hossein MODARRESSI Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Reza SHIRKOOHI Cancer Biology Research Center, Cancer Institute of Iran, Tehran, Iran
  • Bita HASSANI Cancer Biology Research Center, Cancer Institute of Iran, Tehran, Iran
  • Mandana AFSHARPAD Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran
  • Gholamreza RAFIEI Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Gholamreza ABROODI Department of Basic Sciences, Maybod Branch, Islamic Azad University, Yazd, Iran
  • Mir Saeed YEKANINEJAD Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  • Jamal ARFAEE Department of Basic Sciences and Medicine, Zanjan Branch, Islamic Azad University, Zanjan, Iran
  • Seyed Mohammad AKRAMI Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Abstract

No Abstract.

References

1. Zhi F, Shao N, Li B et al (2016). A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma. Sci Rep, 6:32067.
2. Brase JC, Wuttig D, Kuner R, Sültmann H (2010). Serum microRNAs as non-invasive biomarkers for cancer. Mol Can-cer, 9:306.
3. Hellwinkel OJ, Sellier C, Sylvester YM et al (2013). A cancer-indicative microRNA pattern in normal prostate tissue. Int J Mol Sci, 14(3):5239-49.
4. Xu B, Huang Y, Niu X, et al (2015). Hsa‐miR‐146a‐5p modulates androgen‐independent prostate cancer cells apop-tosis by targeting ROCK1. Prostate, 75(16):1896-903.
5. Zhang W, Mao YQ, Wang H et al (2015). MiR-124 suppresses cell motility and ad-hesion by targeting talin 1 in prostate cancer cells. Cancer Cell Int, 15:49.
6. Liu C, Chen Z, Hu X et al (2015). Mi-croRNA-185 downregulates androgen receptor expression in the LNCaP pros-tate carcinoma cell line. Mol Med Rep, 11(6):4625-32.
Published
2019-09-03
How to Cite
1.
SAFFARI M, MODARRESSI MH, SHIRKOOHI R, HASSANI B, AFSHARPAD M, RAFIEI G, ABROODI G, YEKANINEJAD MS, ARFAEE J, AKRAMI SM. Plasma 5-miRNA as Biomarkers for Identifying Prostate Cancer Patients. Iran J Public Health. 48(9):1743-1745.
Section
Letter to the Editor